Naranjillo T4-LF-RS

Solanum quitoense

Naranjillo

SS-NAR SeriesTier 1

Target Trait

500K

SHU

Reported target: 500K SHU

Technical Specifications

Genomic Edits

GC Content

(41%)

Construct Length

5,800 bp

Promoter System

CMV immediate-early

Expression System

pLenti-CMV cationic lipid nanoparticle delivery

Host Strain

Cationic lipofection suspension culture LC-50

Pathway Edits

CHS promoter swap for enhanced phenylpropanoid flux
CYP450-B1 integration at native PAL locus
PAL1 cDNA overexpression cassette (35S:PAL1)

Key Interventions

CS overexpression at 12× native baseline via enhanced 35SPAL1 promoter swap to constitutive CaMV 35S enhancerCYP450-B1 co-factor regeneration via AtCPR overexpression

Application Domains

ResearchPharmaceutical

Intended Use

Enables Naranjillo cross-species capsaicinoid biosynthesis research and pharmaceutical precursor development at 500K SHU.

Access

Request Commercial Access

This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.

No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.

Back to Commercial Catalog